Maze Therapeutics, Inc. (MAZE): Market Valuation

Public company logo of mazetx.com (MAZE)

Maze Therapeutics Inc (MAZE) relies on a robust network of cold-chain carriers for the delivery of biomaterials, establishing a base of clinics and patients to discover new drugs for rare kidney pathologies. This chart of market value demonstrates a capitalization of 1.94. The business's profitability is based on the licensing of genetic discoveries and the sale of targeted drugs to insurance companies for the therapy of severe diseases.

mazetx.com - MAZE Market Value (period 02/01/2025 - 11/16/2026)

Maze Therapeutics Inc - analytical breakdowns and key metrics (MAZE)

Fundamental company analysis:MAZE (Maze Therapeutics Corp)
Original product of Maze Therapeutics Corp

For Maze Therapeutics Inc, which is fighting for patent superiority in genetic medicine, this indicator serves as a measure of the investment attractiveness of its scientific developments. By analyzing the company's market capitalization, an investor assesses the total business value through the lens of supply and demand, where deviations from the norm signal a reassessment of risks amid fierce competition for capital and talent.

Competitors of Maze Therapeutics Inc (MAZE)

Market Capitalization TEM (Tempus AI, Inc)|Market Capitalization Qiagen Group|IONS - Market Value|Market Value repligen.com|RNA: Market Capitalization|Market Valuation CRSP (CRISPR Therapeutics)|Market Value GeneDx Holdings Corp.|Market Capitalization RARE (Ultragenyx Corp)|Market Value Beam Therapeutics (BEAM)|Sarepta Therapeutics, Inc. - Market Capitalization|Market Capitalization TWST (twistbioscience.com)|Market Value TXG (10x Genomics Corp)|Intellia Corp - Market Capitalization|Market Capitalization Stoke Therapeutics STOK|BLFS: Market Capitalization|WVE (Wave Life Sciences) - Market Value|Market Value Sionna Corp|Prime Medicine Inc (PRME) - Market Capitalization|Market Value Taysha Corp (TSHA)|uniQure N.V. (QURE) - Market Capitalization|Market Capitalization MGTX (MeiraGTx Corp)|RGNX: Market Capitalization|SLDB: Market Valuation|OCGN (Ocugen Corp) - Market Capitalization|PACB: Market Capitalization|Market Valuation Benitec Biopharma Inc.|Market Valuation DSGN|Rocket Pharmaceuticals - Market Valuation|Market Capitalization FDMT|LXEO - Market Value|Korro Bio, Inc. - Market Valuation|EDIT: Market Capitalization|SLN - Market Value|PRQR - Market Capitalization|CDXS (Codexis, Inc.) - Market Valuation|Sangamo Therapeutics, Inc. - Market Value|Market Valuation NAUT|Market Valuation Metagenomi, Inc. (MGX)|Market Value precisionbiosciences.com (DTIL)|GBIO - Market Value|Market Capitalization BOLD (Boundless Bio Inc.)|Market Capitalization Exicure, Inc. XCUR|Imunon Inc - Market Capitalization|Market Capitalization phiopharma.com PHIO|Mustang Bio Corp (MBIO) - Market Value|Market Value TransCode Therapeutics (RNAZ)|BNGO (Bionano Genomics) - Market Capitalization|Market Valuation Applied DNA Sciences, Inc. (APDN)|Market Value Bluebird Bio (BLUE)|IPA - Market Value|Market Value omegatherapeutics.com OMGA|singulargenomics.com (OMIC) - Market Value|RGLS - Market Value|Market Capitalization Syros Pharmaceuticals Inc. SYRS|Telesis Bio, Inc. (TBIO) - Market Value|TCON - Market Capitalization|Market Value Unity Biotechnology, Inc.